Thrombosis and Hemostasis Program

Board-certified hematologists and specialized nurse practitioners, physician associates, and nurses in our Thrombosis and Hemostasis Program collaborate with other specialists to provide top-quality patient-centered care. Our specialists regularly participate in research and present at national conferences.
Two people holding hands

Specialty Evaluation and Management

The Thrombosis and Hemostasis Program at The University of Vermont Medical Center (UVMMC) offers specialty evaluation and management of patients with abnormal blood clots and blood-clotting abnormalities as well as chemotherapy-associated thrombosis risk screening.

Thrombosis and Hemostasis Program (UVMMC)

Chemotherapy-Associated Thrombosis Risk Screening

Body

One in five patients undergoing chemotherapy will develop blood clots. We screen all patients with cancer for blood clot risk before chemotherapy starts. If you are at high risk, we prescribe a blood thinner and manage your hematology care to minimize clot risk. Our physician-researchers published the first paper in the country describing the success of this approach.   

Conditions we treat

Body

  • Deep vein thrombosis (DVT) 

  • Pulmonary embolism (PE) 

  • Pregnancy-related thrombosis 

  • Cerebral vein thrombosis 

  • Venous thrombosis in abdominal veins 

  • Thrombophilic disorders 

  • Post-thrombotic syndrome 

  • Bleeding disorders, including hemophilia and von Willebrand’s disease 

A person looks at a scientific sample

Thrombosis, Hemostasis, and Cancer Collaborative at the UVM Cancer Center

The Thrombosis, Hemostasis and Cancer Collaborative at the University of Vermont Cancer Center (UVMCC) was formally established in 2014 and is dedicated to improving the lives of cancer patients by decreasing the vascular complications associated with cancer and its treatments.

Thrombosis, Hemostasis, and Cancer Collaborative (UVMCC)
Two doctors speaking to each other

Vermont Regional Hemophilia Treatment Center (HTC)

The Vermont Regional Hemophilia Treatment Center (HTC) is the only federally funded HTC in Vermont and serves both Vermont and upstate New York patients. It specializes in the treatment of all inherited and acquired bleeding disorders, including Hemophilia, von Willebrand Disease, platelet function.

Vermont Regional Hemophilia Treatment Center (HTC)